Literature DB >> 22364298

Glycogen accumulation in cardiomyocytes and cardiotoxic effects after 3NPA treatment.

Aleksandra Milutinović1, Ruda Zorc-Pleskovič.   

Abstract

Mitochondrial toxin 3-nitropropionic acid (3NPA) is a neurotoxin that inhibits the activity of succinate dehydrogenase, a key enzyme of oxidative energy production, and characteristically provokes neurodegeneration in the striatum, resembling Huntington's disease. 3NPA also affects the activity of glycogen-sinthase-kinase-3b (GSK-3b), an enzyme implicated in glycogen synthesis and in signal transduction. The aim of this study was to evaluate cardiac glycogen content and histopathological changes in the hearts of rats after subchronic treatment with 3NPA.Female adult Wistar rats were treated daily with 30mg/kg of 3NPA subcutaneously 8 days. The control group was treated with normal saline for 8 days. For the comparison of measured parameters between groups we used the Student's t-test (p<0.05). The stereological evaluation of glycogen content in histological sections of the heart was processed with periodic acid-Schiff (PAS). Histochemical procedure showed a significant accumulation of glycogen granules in the 3NPA group (0.028mm(3)/mm(3)±0.022), whereas the hearts of control animals were nearly devoid of glycogen granules (0.002mm(3)/mm(3)±0.001). Haematoxylin-eosin histological staining showed diffuse swelling of cardiomyocytes (3NPA=15.989μm ±1.649; saline=13.456μm ± 0.786), loss of cell cross-striations, lower myofibril volume fraction (3NPA=0.3922mm(3)/mm3 ± 0.0230, saline=0.4550mm(3)/mm3 ± 0.0083), and mononuclear infiltration in the interstitial tissue, mostly along the blood vessels. Sirius red staining showed fibrosis of the heart (3NPA=0.0531mm93)/mm(3)±0.0090, saline=0.0135mm(3)/mm3 ± 0.0051). TUNEL staining showed TUNEL-positive cells in the 3NPA group (2.04cells/mm2 ± 0.92) and almost no TUNEL-positive cells in the saline group (0.27cells/mm2 ± 0.14). This experiment shows that 3NPA-induced histopathological changes in the heart are accompanied by a significant accumulation of glycogen granules in cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22364298      PMCID: PMC4362411          DOI: 10.17305/bjbms.2012.2525

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  42 in total

1.  Early-onset tolerance in rat global cerebral ischemia induced by a mitochondrial inhibitor.

Authors:  H Nakase; A Heimann; R Uranishi; M W Riepe; O Kempski
Journal:  Neurosci Lett       Date:  2000-08-25       Impact factor: 3.046

2.  Hyperactivity and hypoactivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model.

Authors:  C V Borlongan; T K Koutouzis; T B Freeman; R A Hauser; D W Cahill; P R Sanberg
Journal:  Brain Res Brain Res Protoc       Date:  1997-08

3.  Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases.

Authors:  B T Chua; K Guo; P Li
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

4.  Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat.

Authors:  E Brouillet; M C Guyot; V Mittoux; S Altairac; F Condé; S Palfi; P Hantraye
Journal:  J Neurochem       Date:  1998-02       Impact factor: 5.372

Review 5.  Animal models of Huntington's disease.

Authors:  Shilpa Ramaswamy; Jodi L McBride; Jeffrey H Kordower
Journal:  ILAR J       Date:  2007

6.  Chemical preconditioning effect of 3-nitropropionic acid in anesthetized rat heart.

Authors:  Nilufer Nermin Turan; Bilgen Basgut; Eda Aypar; Mustafa Ark; Alper B Iskit; Iclal Cakici
Journal:  Life Sci       Date:  2008-02-29       Impact factor: 5.037

7.  Regulation of GSK-3beta by calpain in the 3-nitropropionic acid model.

Authors:  N Crespo-Biel; A Camins; J Gutiérrez-Cuesta; D Melchiorri; F Nicoletti; M Pallàs; A M Canudas
Journal:  Hippocampus       Date:  2010-08       Impact factor: 3.899

8.  Regulation of fuel metabolism by preexercise muscle glycogen content and exercise intensity.

Authors:  Melissa J Arkinstall; Clinton R Bruce; Sally A Clark; Caroline A Rickards; Louise M Burke; John A Hawley
Journal:  J Appl Physiol (1985)       Date:  2004-07-30

9.  3-Nitropropionic acid activates calpain/cdk5 pathway in rat striatum.

Authors:  Natalia Crespo-Biel; Antoni Camins; Carme Pelegrí; Jordi Vilaplana; Mercè Pallàs; Anna M Canudas
Journal:  Neurosci Lett       Date:  2007-05-26       Impact factor: 3.046

10.  Nestin expression in glial and neuronal progenitors of the developing human spinal ganglia.

Authors:  Katarina Vukojevic; Danijel Petrovic; Mirna Saraga-Babic
Journal:  Gene Expr Patterns       Date:  2010-01-04       Impact factor: 1.224

View more
  4 in total

Review 1.  GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders.

Authors:  Divya Soni; Puneet Kumar
Journal:  Pharmacol Rep       Date:  2022-07-26       Impact factor: 3.919

2.  Lithium chloride could aggravate brain injury caused by 3-nitropropionic acid.

Authors:  Aleksandra Milutinović
Journal:  Bosn J Basic Med Sci       Date:  2016-11-10       Impact factor: 3.363

3.  Comparison of the vitality tests used in the dental clinical practice and histological analysis of the dental pulp.

Authors:  Ana Tenyi; Lidija Nemeth; Aljaž Golež; Ksenija Cankar; Aleksandra Milutinović
Journal:  Bosn J Basic Med Sci       Date:  2022-06-01       Impact factor: 3.759

4.  Inflammatory cells in the ascending aortic aneurysm in patients with type 2 diabetes versus patients with hypertension.

Authors:  Aleksandra Milutinović; Ruda Zorc-Pleskovič
Journal:  Bosn J Basic Med Sci       Date:  2022-04-01       Impact factor: 3.363

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.